Information
-
Trademark
-
97847066
-
International Classifications
-
Filing Date
March 20, 2023
2 years ago
-
Transaction Date
May 03, 2025
26 days ago
-
Status Date
May 02, 2025
27 days ago
-
Location Date
May 02, 2025
27 days ago
-
Status Code
653
-
Current Location
TMO LAW OFFICE 130
Employee Name
DUONG,ANGELA GAW
-
Attorney Docket Number
081844.0006
Attorney Name
Courtney Thompson
Law Office Assigned Location Code
O30
-
Owners
Mark Drawing Code
4
Mark Identification
TILRAY BRANDS
Case File Statements
- GS0411: Providing entertainment information in the field of cannabis culture, hemp culture, CBD culture, beverages, cosmetics, and advanced technology via a website; providing news via a website in the nature of current event reporting in the field of cannabis and cannabis culture, hemp and hemp culture, CBD and CBD culture, beverages, cosmetics and high- technology; educational services and patient educational services, namely, providing on-line non-downloadable audio recordings, providing on-line non-downloadable visual recordings; educational services and patient educational services, namely, providing seminars, workshops, classes and training sessions all in the field of medicinal marijuana, cannabis, hemp and CBD and distribution of printed educational materials in the nature of books, pamphlets, articles, magazines, and newsletters in connection therewith in the field of medical marijuana, cannabis, hemp, and CBD in connection therewith;
- GS0051: Hemp related products, namely, medicinal oils, other than essential oils; hemp related products, namely, salves for the treatment of chronic pain, joint pain and anxiety; hemp related products, namely, concentrated pastes in the nature of medicated skin care preparations; hemp related products, namely, tinctures in the nature of herbal alcohol tinctures with extracts derived solely from hemp plants for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; hemp related products, namely, tablets and capsules containing hemp for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; medicinal oils, other than essential oils, medicated multipurpose salves, concentrated pastes in the nature of medicated skin care preparations, herbal tinctures in the nature of herbal alcohol tinctures with resins and oils derived solely from hemp plants for medical purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes containing hemp for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes containing derivatives of hemp, namely, resins and oils for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; medicated products, namely, topical skin creams, bar and liquid soaps, bath additives, namely, bath herbs, bath oils, body creams, body oils, face and body lotions, face and body milk, face lotion, and skin care preparations, all of the foregoing containing derivatives of hemp in the nature of resins and oils, for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; personal sexual lubricants; transdermal patches containing hemp for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oral sprays containing hemp for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; hemp for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; hemp related product, namely, medicinal oils, other than essential oils, for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; medicinal oils, other than essential oils, derived from hemp for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; all of the foregoing containing or derived from cannabis or hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent dry weight basis and not containing CBD
- GS0361: Financial investment in companies in the healthcare industry, the medicinal marijuana industry, the cannabis industry, the hemp industry, the CBD industry, the alcohol industry, the beverage industry, the cosmetic industry, and high-technology industry; distribution of dividends, profits, capital gains, cash and securities from businesses in the healthcare industry, the medicinal marijuana industry, the cannabis industry, the hemp industry, the CBD industry, the alcohol industry, the beverage industry, the cosmetic industry and high-technology industry; Holding company services, namely, investment management services performed for others;
- GS0351: Development, management and operation of businesses, namely, advisory services for business management in in the healthcare industry, the medicinal marijuana industry, the cannabis industry, the hemp industry, the CBD industry, alcoholic and non-alcoholic beverage industry, cosmetic industry, and high-technology industry; advice and information concerning commercial business management; business management supervision; business planning; providing a website featuring information featuring the ratings, reviews and recommendations on medicinal marijuana, hemp, and CBD products for commercial purposes posted by users via a website
- GS0341: Dried cannabis or dried hemp for smoking; derivatives of cannabis or hemp, namely, resins and hemp oils, for oral vaporizers for smoking, other than essential oils; smokers' articles, namely, smoking pipes sold empty, pouches for use with cannabis or hemp, lighters for smokers, oral vaporizers for smokers sold empty, grinders for use with cannabis or hemp; all of the foregoing containing, derived from, or for use with cannabis or hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent dry weight basis
- GS0441: Providing information in the field parenting concerning CBD abuse and addiction via a website; Providing health and wellness information about benefits of medicinal marijuana and cannabis, hemp, and CBD, operation and research related to medicinal marijuana, cannabis, hemp and CBD via a website; providing health and wellness information in the field of medicinal marijuana, hemp, and CBD and regarding indications and effects of particular cannabis strain via a website; consulting services in the field of medicinal use of marijuana, cannabis, hemp, CBD, and their derivatives
- DS0000: BRANDS
Case File Event Statements
-
3/23/2023 - 2 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
4/11/2023 - 2 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
11/8/2023 - a year ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
11/13/2023 - a year ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
11/13/2023 - a year ago
5 - ASSIGNED TO EXAMINER
Type: DOCK
-
11/30/2023 - a year ago
6 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
11/30/2023 - a year ago
7 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
11/30/2023 - a year ago
8 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
2/28/2024 - a year ago
9 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
2/28/2024 - a year ago
10 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
4/19/2024 - a year ago
15 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
2/28/2024 - a year ago
11 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
4/11/2024 - a year ago
12 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
4/11/2024 - a year ago
13 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
4/11/2024 - a year ago
14 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
4/19/2024 - a year ago
16 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
4/19/2024 - a year ago
17 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
4/29/2024 - a year ago
18 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
4/29/2024 - a year ago
19 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
4/29/2024 - a year ago
20 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
4/29/2024 - a year ago
21 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
4/29/2024 - a year ago
22 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
5/14/2024 - a year ago
23 - WITHDRAWN FROM PUB - OG REVIEW QUERY
Type: PBCR
-
5/16/2024 - a year ago
24 - PREVIOUS ALLOWANCE COUNT WITHDRAWN
Type: ZZZX
-
9/3/2024 - 8 months ago
29 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
6/4/2024 - 11 months ago
26 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
6/4/2024 - 11 months ago
27 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
6/4/2024 - 11 months ago
25 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
9/3/2024 - 8 months ago
30 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
9/30/2024 - 8 months ago
31 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
9/3/2024 - 8 months ago
28 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
9/30/2024 - 8 months ago
34 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
9/30/2024 - 8 months ago
35 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
9/30/2024 - 8 months ago
33 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
9/30/2024 - 8 months ago
32 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
10/24/2024 - 7 months ago
37 - PREVIOUS ALLOWANCE COUNT WITHDRAWN
Type: ZZZX
-
10/22/2024 - 7 months ago
36 - WITHDRAWN FROM PUB - OG REVIEW QUERY
Type: PBCR
-
1/10/2025 - 4 months ago
39 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
1/10/2025 - 4 months ago
38 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
4/3/2025 - a month ago
41 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
4/3/2025 - a month ago
43 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
1/10/2025 - 4 months ago
40 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
4/3/2025 - a month ago
42 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
5/2/2025 - 27 days ago
46 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Type: GNS3
-
5/2/2025 - 27 days ago
44 - SUSPENSION LETTER WRITTEN
Type: CNSL
-
5/2/2025 - 27 days ago
45 - LETTER OF SUSPENSION E-MAILED
Type: GNSL